2017Zhongguo jiceng yiyaoRequires access

Application of CD10, desmin and vimentin in differential diagnosis of special types of uterine tumors

Li Li, Zhaojun Wang, Huajing Zhang, Pengfei Dou, Tengzhou Zhang

Open publisher page 0 citations

Abstract

Objective To study the application value of CD10, desmin and vimentin in the diagnosis and differential diagnosis of special types of uterine tumors. Methods The clinical data of 79 cases of special types of uterine cancer were retrospectively analyzed.CD10, desmin and vimentin were detected respectively by immunohistochemical streptavidin-perosidase(SP) method. Results The positive rates of CD10 in endometrial stromal sarcoma, epithelioid leiomyoma, atypical leiomyoma, leiomyosarcoma, carcinosarcoma were 76.2%, 0.0%, 13.3%, 30.8%, 75.0%, respectively.The positive rates of vimentin in endometrial stromal sarcoma, epithelioid leiomyoma, atypical leiomyoma, leiomyosarcoma, carcinosarcoma were 100.0%, 5.6%, 0.0%, 46.2%, 83.3%, respectively.The positive rates of desmin in endometrial stromal sarcoma, epithelioid leiomyoma, atypical leiomyoma, leiomyosarcoma, carcinosarcoma were 0.0%, 61.1%, 53.3%, 30.8%, 0.0%, respectively.The positive rates of vimentin and CD10 in endometrial stromal sarcoma and carcinosarcoma were all significantly higher than those in atypical leiomyoma, epithelioid leiomyoma(CD10: χ2=23.255, 13.829, 15.880, 8.102, all P=0.000; vimentin: χ2=35.159, 36.000, 15.556, 16.440, all P=0.000). The positive rates of desmin in atypical leiomyoma, epithelioid leiomyoma tissues were significantly higher than those in endometrial interstitial sarcomas, carcinosarcoma(χ2=11.480, 6.717, 17.875, 9.097, all P=0.000). Conclusion CD10, desmin and vimentin can be used as sensitive indicators for the differential diagnosis of uterine tumors with special types. Key words: Uterine neoplasms; CD10; Desmin; Vimentin; Diagnosis, differential

About this research paper

What this paper is about

Objective To study the application value of CD10, desmin and vimentin in the diagnosis and differential diagnosis of special types of uterine tumors. Methods The clinical data of 79 cases of special types of uterine cancer were retrospectively analyzed.CD10, desmin and vimentin were detected respectively by immunohistochemical streptavidin-perosidase(SP) method. Results The positive rates of CD10 in endometrial stromal sarcoma, epithelioid leiomyoma, atypical leiomyoma, leiomyosarcoma, carcinosarcoma were 76.2%, 0.0%, 13.3%, 30.8%, 75.0%, respectively.The positive rates of vimentin in endometrial stromal sarcoma, epithelioid leiomyoma, atypical leiomyoma, leiomyosarcoma, carcinosarcoma were 100.0%, 5.6%, 0.0%, 46.2%, 83.3%, respectively.The positive rates of desmin in endometrial stromal sarcoma, epithelioid leiomyoma, atypical leiomyoma, leiomyosarcoma, carcinosarcoma were 0.0%, 61.1%, 53.3%, 30.8%, 0.0%, respectively.The positive rates of vimentin and CD10 in endometrial stromal sarcoma and carcinosarcoma were all significantly higher than those in atypical leiomyoma, epithelioid leiomyoma(CD10: χ2=23.255, 13.829, 15.880, 8.102, all P=0.000; vimentin: χ2=35.159, 36.000, 15.556, 16.440, all P=0.000). The positive rates of desmin in atypical leiomyoma, epithelioid leiomyoma tissues were significantly higher than those in endometrial interstitial sarcomas, carcinosarcoma(χ2=11.480, 6.717, 17.875, 9.097, all P=0.000). Conclusion CD10, desmin and vimentin can be used as sensitive indicators for the differential diagnosis of uterine tumors with special types. Key words: Uterine neoplasms; CD10; Desmin; Vimentin; Diagnosis, differential

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the application value of CD10, desmin and vimentin in the diagnosis and differential diagnosis of special types of uterine tumors. Methods The clinical data of 79 cases of special types of uterine cancer were retrospectively analyzed.CD10, desmin and vimentin were detected respectively by immunohistochemical streptavidin-perosidase(SP) method. Results The positive rates of CD10 in endometrial stromal sarcoma, epithelioid leiomyoma, atypical leiomyoma, leiomyosarcoma, carcinosarcoma were 76.2%, 0.0%, 13.3%, 30.8%, 75.0%, respectively.The positive rates of vimentin in endometrial stromal sarcoma, epithelioid leiomyoma, atypical leiomyoma, leiomyosarcoma, carcinosarcoma were 100.0%, 5.6%, 0.0%, 46.2%, 83.3%, respectively.The positive rates of desmin in endometrial stromal sarcoma, epithelioid leiomyoma, atypical leiomyoma, leiomyosarcoma, carcinosarcoma were 0.0%, 61.1%, 53.3%, 30.8%, 0.0%, respectively.The positive rates of vimentin and CD10 in endometrial stromal sarcoma and carcinosarcoma were all significantly higher than those in atypical leiomyoma, epithelioid leiomyoma(CD10: χ2=23.255, 13.829, 15.880, 8.102, all P=0.000; vimentin: χ2=35.159, 36.000, 15.556, 16.440, all P=0.000). The positive rates of desmin in atypical leiomyoma, epithelioid leiomyoma tissues were significantly higher than those in endometrial interstitial sarcomas, carcinosarcoma(χ2=11.480, 6.717, 17.875, 9.097, all P=0.000). Conclusion CD10, desmin and vimentin can be used as sensitive indicators for the differential diagnosis of uterine tumors with special types. Key words: Uterine neoplasms; CD10; Desmin; Vimentin; Diagnosis, differential

Key concepts: Desmin, Leiomyosarcoma, Carcinosarcoma, Vimentin, Medicine, Leiomyoma, Pathology, Endometrial stromal sarcoma

Related papers

Back to paper searchBrowse research topicsOriginal source
Application of CD10, desmin and vimentin in differential diagnosis of special types of uterine tumors — Research Paper | ScholarLens